|
注册号: Registration number: |
ChiCTR2000038939 |
|
最近更新日期: Date of Last Refreshed on: |
2021-01-04 09:59:14 |
|
注册时间: Date of Registration: |
2020-10-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
不同程度烧伤创面病毒组学研究 |
|
Public title: |
Skin virome and its association with the host microbiome in patients with moderate to severe burn injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同程度烧伤创面病毒组学研究 |
|
Scientific title: |
Skin virome and its association with the host microbiome in patients with moderate to severe burn injury |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李健 |
研究负责人: |
吴军 |
|
Applicant: |
Jian Li |
Study leader: |
Jun Wu |
|
申请注册联系人电话: Applicant telephone: |
+86 13640570136 |
研究负责人电话:
Study leader's |
+86 13983130289 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
seraph-2004@163.com |
研究负责人电子邮件: Study leader's E-mail: |
junwupro@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
深圳市福田区笋岗西路3002号 |
研究负责人通讯地址: |
深圳市福田区笋岗西路3002号 |
|
Applicant address: |
3002 Sungang Road West, Futian District, Shenzhen |
Study leader's address: |
3002 Sungang Road West, Futian District, Shenzhen |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
深圳市第二人民医院 |
||
|
Applicant's institution: |
Shenzhen Second People's Hospital |
||
|
研究负责人所在单位: |
深圳市第二人民医院 |
||
|
Affiliation of the Leader: |
Shenzhen Second People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
20200901001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
深圳市第二人民医院临床科研伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of Shenzhen Second People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-09-17 00:00:00 | ||
|
伦理委员会联系人: |
陈旭红 |
||
|
Contact Name of the ethic committee: |
Xuhong Chen |
||
|
伦理委员会联系地址: |
深圳市福田区笋岗西路3002号 |
||
|
Contact Address of the ethic committee: |
3002 Sungang Road West, Futian District, Shenzhen |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
深圳市第二人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shenzhen Second People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
深圳市福田区笋岗西路3002号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
3002 Sungang Road West, Futian District, Shenzhen |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
高水平医院建设项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
High-level hospital construction project |
||||||||||||||||||||||
|
研究疾病: |
烧伤 |
||||||||||||||||||||||
|
Target disease: |
Burn injury |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
基础科学研究 |
||||||||||||||||||||||
|
Study type: |
Basic Science |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
析因分组(即根据危险因素或暴露因素分组) |
||||||||||||||||||||||
|
Study design: |
Factorial |
||||||||||||||||||||||
|
研究目的: |
本项目研究拟计划对不同程度烧伤患者(浅二度、深二度、三度)采集的样本进行病毒组检测及微生物组检测。本研究的目的如下: 1)从多组学角度探讨病毒多样性与烧伤严重程度、创面微生物组相关性; 2)鉴定能够在创面定植的新病毒,并评估其与感染、预后的相关性; 3)皮肤移植前创面病毒组及微生物组测序,结合临床指标鉴定及筛选与移植物存活、疤痕组织形成相关功能指示菌或病毒。 |
||||||||||||||||||||||
|
Objectives of Study: |
The aims of this study are to: 1) Identify the diversity of burn injured skin wounds virome and compare to the healthy skin virome; 2) Identify virome composition that are associated with different clinical stages of burn injury; 3) Identify novel viruses that are able to colonize in the skin wounds, which are not possible to be discovered by analyzing healthy skin owing to the low viral abundances. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
严重免疫缺陷患者如HIV |
||||||||||||||||||||||
|
Exclusion criteria: |
Immunodeficiency disease such as HIV. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-11-01 00:00:00至 To 2023-11-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-11-01 00:00:00 至 To 2021-11-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Non-randomization |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
项目组根据研究进程择期选择具体方式公开原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
According to the progress of the research, raw research data should be made freely available to all researchers in specific ways |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究者根据受试者的原始观察记录,将数据及时、完整、正确、清晰地载入病例记录表。将数据录入相应的数据库系统。电子数据文件分类保存,并有多个备份保存于不同记录介质上,妥善保存,防治损坏。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Based on the original observation records,researchers will completely write accurate data into case report forms in time. Input the data into corresponding database system.Electronic data will be conserved and backup. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |